Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-787 phase 2b trial in acute uncomplicated seasonal influenza A
2014-004068-39Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pimodivir in Influenza A infection and influenza (4 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Area under the curve of log10 nasal viral load from baseline to Day 8. Started Nov 2014; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A infectioninfluenza
Beyond the preview
Go deeper on 2014-004068-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004068-39.